ROBIN SHERRINGTON

CIK 00016199621 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001619962

Recent Transactions

50 trades

Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-03-11+65,000→ 65,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-03-07−1,234→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$9.85/sh+7,407→ 16,824 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$45.96/sh−215→ 9,417 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$9.85/sh+1,234→ 9,632 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$45.96/sh−1,289→ 15,535 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-03-07−7,407→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$46.15/sh−1,019→ 14,516 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2024-03-07$46.30/sh−6,118→ 8,398 total
Other
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-12-29−8,398→ 8,398 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-03-10+75,000→ 75,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-01$38.81/sh−6,121→ 60,675 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-01$4.75/sh+50,000→ 66,796 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-01$38.03/sh−35,103→ 25,572 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-09-01$38.80/sh−8,776→ 16,796 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-09-01−50,000→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-31$38.57/sh−21,352→ 16,796 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Options (Right to Buy)
2022-08-31−5,000→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-31$2.67/sh+17,488→ 34,720 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-31$4.75/sh+5,000→ 39,720 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-08-31$37.86/sh−1,572→ 38,148 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Options (Right to Buy)
2022-08-31−17,488→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-10+75,000→ 75,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-04−1,234→ 0 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$30.15/sh−5,000→ 27,232 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$3.67/sh+6,172→ 38,942 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$3.67/sh+1,234→ 33,466 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-03-04−6,172→ 0 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$31.42/sh−696→ 32,770 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$30.23/sh−5,000→ 17,232 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$31.05/sh−5,000→ 22,232 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2022-03-04$30.56/sh−6,710→ 32,232 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-28$3.76/sh+12,345→ 29,141 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-28$18.81/sh−2,912→ 32,232 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-28$18.91/sh−2,192→ 38,299 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-05-28−12,345→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-05-28−13,374→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-28$3.85/sh+13,374→ 40,491 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-28$18.81/sh−3,155→ 35,144 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2021-05-28$18.91/sh−2,024→ 27,117 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2021-03-12+65,000→ 65,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-06-01−8,230→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2020-06-01$3.56/sh+8,230→ 18,426 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2020-06-01$13.70/sh−1,630→ 16,796 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2020-03-12+65,000→ 65,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-16+45,000→ 45,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2019-09-12−6,172→ 0 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-12$9.38/sh−1,868→ 10,196 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2019-09-12$3.07/sh+6,172→ 12,064 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2018-03-15−3,086→ 0 total

Companies

Xenon Pharmaceuticals Inc.
See Remarks
$XENE

Recent Filings

Address

C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY

BURNABY, A1, V5G4W8

View on SEC.gov